New York Presbyterian Hospital Cornell Campus Program

Program Identity & Fit

This is an academic, university-based Nuclear Medicine residency embedded within Weill Cornell Medicine's Department of Radiology, explicitly framed around "Molecular Imaging and Therapeutics" rather than traditional nuclear medicine, reflecting an identity built on emerging radiopharmaceutical and theranostic practice. The program offers flexible one-, two-, or three-year ACGME-accredited tracks and gives residents access to an in-house radiopharmacy, on-site cyclotron, PET/MRI, PET/CT, and SPECT/CT infrastructure, dedicated therapeutic infusion spaces, and early-phase trial capacity through the Molecular Imaging Innovations Institute (MI4/MI3), connecting clinical training directly to investigational radiopharmaceuticals and phase 0/1 studies. Training is structured through short, rotating blocks across general nuclear medicine, PET, cardiac, therapeutic, and radiopharmacy services, supplemented by collaborative physics instruction with Memorial Sloan Kettering, and residents are strongly encouraged (not merely permitted) toward scholarly and research engagement. Graduates commonly pursue academic careers, fellowships, or dual certification in radiology or radiation oncology, indicating the program values residents oriented toward molecular imaging innovation and the translational/theranostic future of the field rather than solely diagnostic volume.